Sclerosing Cholangitis
📧 Sign up to get email alerts when something new happens for Sclerosing Cholangitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: CM-101 in PSC Patients -The SPRING Study [Phase 2]
Phase 2 clinical trial results for CM-101 in patients with primary sclerosing cholangitis (PSC) have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Vancomycin for Primary Sclerosing Cholangitis [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating vancomycin for primary sclerosing cholangitis has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating sulfasalazine for the treatment of Primary Sclerosing Cholangitis.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: A Pilot Study Examining Diet in Primary Sclerosing Cholangitis [NA]
A completed pilot trial evaluating dietary interventions in Primary Sclerosing Cholangitis. The study explored whether diet modifications co…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the efficacy and safety of Volixibat for itching in patients with Primary Sc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) [Phase 2]
Phase 2a study evaluating the safety, tolerability, and pharmacokinetics of PLN-74809 in patients with primary sclerosing cholangitis has co…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Repeatability and Reproducibility of Multiparametric MRI
A clinical trial update reports on the repeatability and reproducibility of multiparametric MRI for evaluating liver diseases across several…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study of SIPLIZUMAB in AILD and LT Patients [Phase 1]
Phase 1 clinical trial of SIPLIZUMAB for autoimmune liver disease and liver transplant-related conditions is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: TruGraf Liver Gene Expression Serial Test
The TruGraf Liver Gene Expression Serial Test is enrolling by invitation at Washington University for autoimmune liver diseases, including a…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Genomics of Primary Sclerosing Cholangitis (PSC)
A Mayo Clinic-sponsored genomics study on Primary Sclerosing Cholangitis has completed, according to the clinical trial update.
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis [Phase 2]
Phase 2 study update reporting results for EP547 in patients with cholestatic pruritus due to primary biliary cholangitis or primary scleros…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis [Phase 2]
Phase 2 trial evaluating the safety and tolerability of A3907 in adults with Primary Sclerosing Cholangitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Vancomycin in Primary Sclerosing Cholangitis in Italy [Phase 2]
A Phase 2 clinical trial is evaluating vancomycin for primary sclerosing cholangitis in Italy. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: A Study of NGM282 in Patients With Primary Sclerosing Cholangitis [Phase 2]
A Phase 2 study of NGM282 for primary sclerosing cholangitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis. [Phase 2]
A Phase 2 clinical trial is evaluating oral hymecromone for treating adolescents and adults with primary sclerosing cholangitis and is curre…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis [Phase 2]
A Phase 2 clinical trial is evaluating fecal microbiota transplantation for Primary Sclerosing Cholangitis; the study is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC) [Phase 3]
Phase 3 clinical trial evaluating Norucholic Acid Tablets for Primary Sclerosing Cholangitis; the study status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT [EARLY_Phase 1]
An early-phase study update on detecting integrin αvβ6 with PET/CT in patients with idiopathic pulmonary fibrosis, primary sclerosing cholan…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC [Phase 2]
A Phase 2 trial of seladelpar for primary sclerosing cholangitis was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Endoscopy and Primary Sclerosing Cholangitis
A clinical trial evaluating the use of endoscopy in patients with Primary Sclerosing Cholangitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: CM-101 in PSC Patients -The SPRING Study [Phase 2]
Phase 2 clinical trial update for CM-101 in patients with primary sclerosing cholangitis (PSC) is active not recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Study of Cilofexor in Adults With Primary Sclerosing Cholangitis [Phase 3]
A Phase 3 trial of cilofexor in adults with primary sclerosing cholangitis was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis [Phase 1]
Phase 1 trial assessing safety and tolerability of cilofexor in participants with primary sclerosing cholangitis and compensated cirrhosis; …
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of HK-660S in patients with primary sclerosing cholangitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) [Phase 2]
Phase 2 study evaluating safety and efficacy of DUR-928 in subjects with primary sclerosing cholangitis was terminated with results posted.